All lobbying filings

Crossroads Strategies, LLC

Crossroads Strategies, LLC filed a Q3 report for Alkermes, Inc. on October 17, 2026, reporting $60,000 in lobbying income.

Lobbying for Alkermes, Inc. · biopharmaceutical company

As filed: CROSSROADS STRATEGIES, LLC for ALKERMES, INC.

All filings by Crossroads Strategies, LLC · Everything Alkermes, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 17, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Policiesimpacting pharmaceutical development, patient access, drug pricing, and supply chain.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.